Toxicity studies on 4-chloro-5-sulfamoylanthranilic acid the degradation product of a loop diuretic furosemide

Research Journal of Pharmacology

Volumn 3, Issue 4, 2009, Pages 63-77

  Al Omar, Ibraheem A ^a   Al Ashban, Riyadh M ^a   Shah, Arif H ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

4 chloro 5 sulfamoylanthranilic acid; Acute toxicity; Chronic toxicity; Furosemide; Subacute toxicity; Swiss albino mice

Indexed keywords

4 CHLORO 5 SULFAMOYLANTHRANILIC ACID; ALANINE AMINOTRANSFERASE; ANTHRANILIC ACID; ASPARTATE AMINOTRANSFERASE; CLASTOGEN; CREATININE; FUROSEMIDE; GLUCOSE; UNCLASSIFIED DRUG; UREA;

ACUTE TOXICITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOTOXICITY; CHRONIC TOXICITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DEGRADATION; GLUCOSE BLOOD LEVEL; HEPATITIS; HISTOPATHOLOGY; MALE; MORTALITY; MOUSE; NEPHROTOXICITY; NONHUMAN; TOXICITY TESTING; UREA BLOOD LEVEL;

EID: 77953408324     PISSN: 18159362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Al-Ashban, R.M., D.A. Barrett and A.H. Shah, 2005. Effect of chronic treatment with ethanolic extract of Teucrium polium in mice. J. Herb. Spices Med. Plants, 11 (4): 27-36. INIST-CNRS, Cote INIST: 26084, 35400013935326.0040. DOI: 10.1300/J044v11n04-04.
2. Ali, S.K.M., 2006. Renal calculi complicating short-term furosemide therapy after congenital heart surgery. Congenit. Heart Dis., 1 (5): 251-253. PMID: 18377534. DOI: 10.1111/j.1747-0803.2006.00044.x.
3. Al-Harbi, M.M., S. Qureshi, M.M. Ahmed, S. Rafatullah and A.H. Shah, 1994. Effect of Commiphora molmol (oleo-gum-resin) on cytological and biochemical changes induced by cyclophosphamide in mice. Am. J. Chin. Med. 22: 77-82. DOI: 10.1142/50192415x940-00103. PMID: 7518189.
4. Amdur, M.O., J. Doull, D. Curtis, C.D. Klaassen and L.J. Casarett, 1991. Casrett and Boull's Toxicology. The Basic Science of Poisons. 4th Edn. McGraw-Hill Co., New York. ISBN: 0071052399/0-07-105239-9.
5. Asaeda, N., M. Shinoda, S. Tamano, E. Ikawa, T. Yoshiyasu, H. Iwai, N. Nagai, Y. Tagawa and M. Koide, 1984. Effect of diuretic, azosemide (SK-110) in combination with antibiotic cephaloridine on kidney. J. Toxicol. Sci., 9 (1): 73-88. PMID: 6492 216.
6. Astashkin, E.I., V.I. Sarbash, M.G. Glezer, N.A. Kosheleva and I.F. Tishchenkova, 1988. Clinical and experimental studies of the combined use of dibasol and furosemide. Farmakol, Toksikol (Farmakologiia i toksikologiia, USSR), 51 (1): 60-62. PMID: 3360110.
7. Bagshaw, S.M., A. Delaney, M. Haase, W.A. Ghali and R. Bellomo, 2007. Poop diuretics in the management of acute renal failure: A systematic review and meta-analysis. Crit. Care Resurc., 9(1): 60-68. DOI: 10.1093/ndtplus/sfn199. PMID: 17352669.
8. Bagshaw, S.M., R. Bellomo and J.A. Kellum, 2008. Oliguria, volume overload and loop diuretics. Crit. Care Med., 36 (4 Suppl): S172-178. DOI: 10.1097/CCM.0b013e318168c92f. PMPD: 18382190.
9. Beerman, B., E. Dalen, B. Lindstrom and A. Rosen, 1975. On the fate of furosemide in man. Eur. J. Clin. Pharmacol., 9 (1): 51-61. PMID: 1233253.
10. Board on Environmental Studies and Toxicology (BEST), 2006. Toxicity testing for assessment of environmental agents: Interim report. The National Academics Press, USA. ISBN: 10-0-309-10092-5, 13-978-0-309-10092-2.
11. Black, H.E., 1986. Renal toxicity of non-steroidal antiinflammatory drugs. Toxicol. Pathol., 14(1): 83-90. DOI: 10.1177/019262338601400110. PMID: 3487106.
12. Brater, D.C., 1983. Pharmacodynamic considerations in the use of diuretics. Annu. Rev. Pharmacol. Toxicol., 23: 45-62. PMID: 6347052. IDS No. QN055.
13. Chan, P.K. and A.W. Hayes, 2007. Acute Toxicity and Eye Irritancy. 5th Edn. In: Hayes, A.W. (Ed.). Principles and Methods of Toxicology. New York: Raven Press, pp: 579-647. ISBN: 10-084933778X, 13-97808 49337789.
14. Chan, P.K., G.P. O'hara and A.W. Hayes, 1982. Principles and Methods of Acute and Sub-Chronic Toxicity. 2nd Edn. In: Hayes, A.W. (Ed.). Principles and Methods of Toxicology. Raven Press, NY, pp: 1-51. ISBN: 08900-44708.
15. Chemtob, S., B.S. Kaplan, J.R. Sherbotie and J.V. Aranda, 1989. Pharmacology of diuretics in the newborn. Pediatr. Clin. North Am., 36 (5): 1231-1250. PMID: 2677940. CODEN PCNAA8. INISP-CNRS. Cote INISP: 9064.
16. Chuen, M.J. and R.J. MacFadyen, 2006. Dose-dependent association between use of diuretics and mortality in advanced systolic heart failure. Am. J. Cardiol., 97, 98 (12, 10): 1759-1764, 1416-1417. PMID: 17134642.
17. Costta, S., F. Gallini, M.P. De Carotis, C. Patella, L. Manggio, C. Zecca and C. Romagnoli, 2009. Urinary aldosterone excretion and renal function in extremely-low-birth-weight infants following acute furosemide therapy. Neonatology, 96 (3): 171-174. PMID: 19332997. DOI: 10.1159/000210090.
18. Cruz, J.E., D.D. Maness and G.J. Yakatan, 1979. Kinetics and mechanism of hydrolysis of furosemide. Int. J. Pharm. Amsterdam, 2: 275-281. ISBN: 0090-9556/98/2605-0401-0407$02.00/0.
19. da Cunha, S., J. Cunha-Bastos, J.B. Salles, M.C. Silva, V.L. Cunha-Bastos and C.A. Mandarim-de-Lacerda, 2007. Cardiac alterations in furosemide-treated thiamine-deprived rats. J. Card. Fail., 13 (9): 774-784. DOI: 10.1016/j.cardfail.2007.06.729. PMID: 17996828.
20. Eshaghian, S., T.B. Horwich and G.C. Fonarow, 2006. Relation of loop diuretic dose to mortality in advanced heart failure. Am. J. Cardiol., 98 (10): 1416-1417. DOI: 10.1016/j.amjcard.2006.08.007. PMID: 17134642.
21. Fadel, S., R. Karmaili and E. Cogan, 2009. Safety of furosemide administration in an elderly woman recovered from thiazide-induced hyponatremia. Eur. J. Int. Med., 20(1): 30-34. DOI: 10.1016/j.ejim.2008.04.006. PMID: 19237089. PII: S0953-6205(08)00135-0. http//www.ejinme.com/article/S0953- 6205(08)00135-0/abstract.
22. Hardman, J.G., L.E. Limbird and A.G. Gilman, 2001. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 10th Edn.: McGraw-Hill, New York, ISBN: 0-07-135469-7.
23. Harnischfeger, G., 1985. Qualitatskontrolle von Phytopharmaka/Quality Control of Herbal Drugs. In: Sucker, H. and P. Fuchs (Eds.). Arbeitstechniken der Pharmazeutischen Industrie/Working Techniques of Pharmaceutical Industry, Band 6, Georg Thieme Verlag Stuttgart, Germany. ISBN: 3-13-673401-7.
24. Hayes, A.W., 2001. Principles and Methods of Toxicology. 4th Edn. Taylor and Francis, Philadelphia, PA 19106, USA, pp: 1887. ISBN: 1-560-814-2,RA1211, 742000,615.9.dc21.00-037719.
25. Hori, Y., F. Takusagawa, H. Ikadai, M. Uechi, F. Hoshi and S. Higuchi, 2007. Effects of oral administration of furosemide and torsemide in healthy dogs. Am. J. Vet. Res., 68 (10): 1058-1063. DOI: 10.2460/ajvr.68.10.1058, PMID: 17916010.
26. Hsu, Y.J., J.S. Chiu, K.C. Lu, T. Chau and S.H. Lin, 2005. Biochemical and etiological characteristics of acute hyponatremia in the emergency department. J. Emerg. Med., 29 (4): 369-374. PMID: 16243191.
27. Ibrahim, K.E., R.M. Al-Ashban and S.A. El-Sammani, 2009. A study of the toxicity of cat's claw herbal medicine. Res. J. Pharmacol., 3 (3): 52-57. http://medwelljournals.com/fulltext/rjp/2009/52-57.pdf.
28. Isidori, M., A. Nardelli, A. Parrella, L. Pascarella and L. Previtera, 2006. A multi species study to assess the toxic and genotoxic effect of pharmaceuticals: Furosemide and its photoproduct. Chemosphere, 63 (5): 785-793. DOI: 10.1016/j.chemosphere.2005.07.078. PMID: 16213548.
29. Jerie, P., 2007. Milestones of cardiovascular therapy diuretics. Cas. Lek. Cesk., 146 (11): 858-862. PMID: 18069212.http://www.find-health-articles. com/rec-pub-18069212-milestones-cardiovascular-therapy-v-diuretics.htm.
30. Jameela, M., S. Subramanyam and G. Sadasivan, 1979. Clastogenic effects of furosemide on human leukocytes in culture. Mutat. Res., 66 (1): 69-74. PMID: 423907, 0400763.
31. Kapur, G., R.P. Valentini, A.A. Imam and T.K. Mattoo, 2009. Treatment of severe edema in children with nephrotic syndrome with diuretics alone-a prospective study. Clin. J. Am. Soc. Nephrol., 4 (5): 907-913. DOI: 10.2215/CJN.04390808. PMID: 19 406963.
32. Khalil, S.H.A., A.H. Shah and A.H. Al-Shareef, 1993. A reverse phase HPPC method for the determination of chloramphenicol and its hydrolytic product in ophthalmic solutions. Analytical. Lett., 26 (6): 1163-1179. DOI: 10.1080/00032719308019895.
33. Kociol, R., J. Rogers and A. Shaw, 2009. Organ cross talk in the critically ill: The heart and kidney. Blood Purif., 27 (4): 311-320. DOI: 10.1159/000207198. PMID: 19270450.
34. Kopp, S., 2006. Stability testing of pharmaceutical products in a global environment. WHO policy on stability testing. The Secretariats of the World Health Organization's Expert Committee on Specifications for Pharmaceutical Preparations. Informal UK Ltd. www.Rajpharma.com. Regulatory Feature, WHO, pp: 291-294. http://www.who.int/medicines/areas/quality-safety/quality-assurance/ RAJ2006WHOStability.pdf.
35. Lebedev, A.A. and N.A. Petrenko, 1996. The antioxidative properties of furosemide in renal ischemia. Eksp. Klin. Farmakol. Russia, 59 (4): 28-30. PMID: 9026184. http://www.find-health-articles.com/rec-pub-9026184-the-antioxidative- properties-furosemide-renal-ischemia.htm.
36. Liu, J., Y. Liu P. Bullock, and C.D. Klassen, 1995. Suppression of liver cytochrome P 450 by α-hederin: Relevance to hepatoprotection. Toxicol. Applied Pharmacol., 134: 124-131. PMID: 7676446. http://content.nhoindemed.com.
37. Luellmann, H., K. Mohr, L. Hein and D. Bieger, 2005. Color Atlas of Pharmacology, Thieme International. 3rd Revised Exp. Edn ISBN: 10-158890332X, 13-978-15889 03327. http://www.amazon.com/Color-Atlas-Pharmacology-Heinz- Luellmann/Dp/158890332X/ref=pd-sim-b-2/182-8133607-2845059.
38. Majed, A.A., A.A. Al-Yahya, A.M. Al-Bekairi, Al-Shabanah and S. Qureshi, 2005. Genetic and biochemical effects of Ginkgo biloba on somatic and germ cells of mice. Saudi Pharmaceutical. J., 13 (4): 148-157. http://www.ksu.edu.sa/colleges/pharm/SPJ/1304/130403.pdf.
39. Metra, M., S. Nodari, G. Parrinello, P. Bordonali, S. Bugatti, R. Danesi, B. Fontanella, C. Lombardi, P. Milani, G. Verzura, G. Cotter, H. Dittrich and B.M. Massie, 2008. Worsening renal function in patients hospitalized for acute heart failure: Clinical implications and prognostic significance. Eur. J. Heart Fail., 10 (2): 188-195. DOI: 10.1016/j.ejheart.2008.01.011. PMID: 18279773.
40. Mosberg, A.T. and A.W. Hayes, 1989. Sub-chronic Toxicity Testing. 2nd Edn. In: Wallace, H.A. (Ed.). Principles and Methods of Toxicology. Raven Press, NY, pp: 221-236. ISBN: 08900-44708.
41. Nakahama, H., Y. Miwa, A. Yamaji, Y. Fukuhara, M. Yanase, T. Kamada, T. Sonoda, M. Ishibasi and Y. Ichikawa, 1987. The urinary excretion of furosemide and its metabolites on kidney transplant patients. Eur. J. Clin. Pharmacol., 32: 313-316. PMID: 3297734.
42. NTP (National Toxicology Program), 1989. Toxicology and carcinogenesis studies of furosemide (CAS No. 54-31-9) in F344/N rats and B6C3F1 mice (feed studies). Natl. Toxicol. Program Tech. Rep. Ser., 356: 1-190. PMID: 12695785. http://ntp.niehs.nih.gov/go/6972. http://ntp.niehs.nih.gov/ntp/htdocs/LT-rpts/ tr356.pdf. http://ntp.niehs.nih.gov/?objected=07089914-FD E4-C583- 1F13CC110E963972.
43. Qureshi, S., M.M. Al-Harbi, M.M. Ahmed, M. Raza, A.B. Giangreco and A.H. Shah, 1993. Evaluation of genotoxic, cytotoxic and antitumor properties of Commiphora molmol using normal and Ehrlich ascites carcinoma cell-bearing Swiss albino mice. Cancer Chemother. Pharmacol., 33: 130-138. DOI: 10.1007/BF00685330. PMID: 8261571.
44. Reynolds, J.E.F. and K. Parfitt, 1989. Martingale. The Extra Pharmacopoeia. 29th Edn. The Pharmaceutical Press, London, pp: 987-991. ISBN: 0-85369-210-6.
45. Robin, J.F., J.J. Jomer and R.R. Schueler, 1982. Principles and Methods of Acute Ad Sub-chronic Toxicity. In: Wallace, H.A. (Ed.). Principles and Methods of Toxicology. Raven Press, NY, pp: 79-105. ISBN: 08900 44708.
46. Saarela, T., P. Lanning, M. Koivisto and T. Paavilainen, 1999. Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: A study of the incidence and 2 years follow up. Eur. J. Pediatr., 158 (8): 668-672. PMID: 10445348.
47. Sandstrom, P.E., 1986. Probenecid potentiates the hyperglycemic effect, but reduces the diuretic effect of furosemide in mice. Br. J. Pharmacol., 89: 307-312. PMID: 3779212. PMCID: PMC1917023.
48. Sandstrom, P.E. and J. Schlin, 1988. Furosemide causes acute and long-term hyperglycemia and reduces glucose tolerance in mice. Acta. Physiol. Scand, 132: 75-81. PMID: 3066121.
49. Sawaya, G.F. and P.A. Robertson, 1992. Hepatotoxicity with the administration of nifedipine for treatment of preterm labour. Am. J. Obstet. Gynecol., 167 (2): 512-513. PMID: 1497061.
50. Schreuder, M.F., J.A. van Wijk, H.J. van der Horst and A. Bökenkamp, 2008. A boy with cyclic vomiting and an alleged furosemide allergy on the basis of a subpelvic stenosis. Ned. Tijdschr. Geneeskd., 152 (5): 275-277. PMID: 18333543, SID: 78573161.
51. Schwinger, R.H. and E. Erdmann, 1992. Heart failure and electrolyte disturbances. Methods Find. Exp. Clin. Pharmacol., 14 (4): 315-325. PMID: 1507935.
52. Shah, A.H., A.H. Al-Shareef, S. Qureshi and A.M. Ageel, 1998. Toxicity studies on some common spices: Cinnamomum zylanicum and Piper longum. Plant Foods Hum. Nutr., 52: 231-239. DOI: 10.1023/A:1008088323164. PMID: 9950084.
53. Smith, D.E. and L.Z. Benet, 1983. Biotransformation of furosemide in kidney transplant patients. Eur. J. Clin. Pharmacol., 24: 787-790. PMID: 6350024.
54. Smith, M.T. and S. Orrenius, 1984. Studies on Drug Metabolism and Drug Toxicity in Isolated Mammalian Cells. In: Mtchell, J.R. and M.G. Horning (Eds.). Drug Metabolism and Drug Toxicity. American Society for Pharmacology and Experimental Therapeutics, Michigan University, Raven Press, New York, pp: 71-98. ISBN: 0890049971, 9780890049976.
55. Snopek, G., J. Kotlarska, D. Daniewska, T. Zelem, W. Drewniak, A. Krol-Jaskulska and M. Dabrowski, 2008. Use of intermittent ultrafiltration in decompensated, diuretic-resistant heart failure 6 case reports. Kardiol. Pol., 66 (11): 1202-1204. PMID: 19105097.
56. Subramanyam, S. and M. Jameela, 1977. Studies on cytological effects of fursemide on meiotic cells of male mice. Indian. J. Med. Res., 66 (1): 104-113. PMID: 924576.
57. Vargas, F., I. Martinez-Volkmar, J. Sequera, H. Mendez, J. Rojas, G. Fraile, M. Velasquez and R. Medina, 1998. Photo degradation and phytotoxicity studies of furosemide. Involvement of singlet oxygen in the photoinduced hemolysis and lipid per oxidation. J. Photochem. Photobiol. B., 42 (3): 219-225. DOI: 10.1016/S1011-1344(98)00074-8. PMID: 9595711.
58. WHO (World Health Organization), 2004. Stability testing for hot and humid climates. WHO Drug Information, 18 (2): 113FF. www.who.int/ druginformation/vol18num2-2004/D118-2.pdf
59. Williams, D.P., D.J. Antoine, P.J. Butler, R. Jones, L. Randle, A. Payne, M. Howard, I. Gardner, J. Blagg and B.K. Park, 2007. The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: A chemical and biochemical definition of the toxicophore. J. Pharmacol. Exp. Pher., 322 (3): 1208-1220. DOI: 10.1124/jpet.107.125302. PMID: 17556636.
60. Yoshioka, S. and V.J. Stella, 2002. Stability of Drugs and Dosage Forms. Springer Verlag. New York. ISBN: 0306464047.
61. Zeiger, E., 1998. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: Premises, promises and performance. Regul. Toxicol. Pharmacol., 28 (2): 85-95. DOI: 10.1006/rtph.1998.1234. PMID: 9927558.
62. Zila, I., A. Brozmanova, M. Javorka, A. Calkovska and K. Javorka, 2007. Effects of hypovolemia on hyper-capnic ventilatory response in experimental hyper-thermia. J. Physiol. Pharmacol., 58 (Suppl. 5 Pt 2): 781-790. PMID: 1820 4192. www.jpp.krakow.pl.